1. Home
  2. AUPH vs SVM Comparison

AUPH vs SVM Comparison

Compare AUPH & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SVM
  • Stock Information
  • Founded
  • AUPH 1993
  • SVM N/A
  • Country
  • AUPH Canada
  • SVM Canada
  • Employees
  • AUPH N/A
  • SVM N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SVM Precious Metals
  • Sector
  • AUPH Health Care
  • SVM Basic Materials
  • Exchange
  • AUPH Nasdaq
  • SVM Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SVM 906.7M
  • IPO Year
  • AUPH 1999
  • SVM N/A
  • Fundamental
  • Price
  • AUPH $8.86
  • SVM $5.14
  • Analyst Decision
  • AUPH Strong Buy
  • SVM Strong Buy
  • Analyst Count
  • AUPH 2
  • SVM 1
  • Target Price
  • AUPH $11.50
  • SVM $6.75
  • AVG Volume (30 Days)
  • AUPH 2.0M
  • SVM 7.0M
  • Earning Date
  • AUPH 07-31-2025
  • SVM 08-12-2025
  • Dividend Yield
  • AUPH N/A
  • SVM 0.49%
  • EPS Growth
  • AUPH N/A
  • SVM 40.00
  • EPS
  • AUPH 0.27
  • SVM 0.28
  • Revenue
  • AUPH $247,295,000.00
  • SVM $298,895,000.00
  • Revenue This Year
  • AUPH $12.15
  • SVM $1.10
  • Revenue Next Year
  • AUPH $18.31
  • SVM $26.47
  • P/E Ratio
  • AUPH $33.08
  • SVM $19.15
  • Revenue Growth
  • AUPH 29.20
  • SVM 38.90
  • 52 Week Low
  • AUPH $5.20
  • SVM $2.87
  • 52 Week High
  • AUPH $10.67
  • SVM $5.32
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 64.10
  • SVM 71.35
  • Support Level
  • AUPH $7.36
  • SVM $4.45
  • Resistance Level
  • AUPH $9.10
  • SVM $4.94
  • Average True Range (ATR)
  • AUPH 0.44
  • SVM 0.20
  • MACD
  • AUPH 0.10
  • SVM 0.06
  • Stochastic Oscillator
  • AUPH 89.53
  • SVM 99.58

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

Share on Social Networks: